These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 17900472

  • 1. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) study.
    Hooda A, Kim S, Kanna B.
    Am J Kidney Dis; 2007 Oct; 50(4):687-8. PubMed ID: 17900472
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The optimal hemoglobin in dialysis patients- a critical review.
    Singh AK, Fishbane S.
    Semin Dial; 2008 Oct; 21(1):1-6. PubMed ID: 18251947
    [Abstract] [Full Text] [Related]

  • 4. Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients.
    Chan K, Moran J, Hlatky M, Lafayette R.
    Nephrol Dial Transplant; 2009 Jun; 24(6):1956-62. PubMed ID: 19176685
    [Abstract] [Full Text] [Related]

  • 5. Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point?
    Covic A, Seica A, Gusbeth-Tatomir P, Goldsmith D.
    J Nephrol; 2008 Jun; 21(4):478-84. PubMed ID: 18651536
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?
    Vaziri ND.
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):436-45. PubMed ID: 18542121
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance and prognostic value of anemia in heart failure patients].
    Grzesło A, Jankowska EA, Witkowski T, Petruk-Kowalczyk J, Banasiak W, Ponikowski P.
    Kardiol Pol; 2007 Feb; 65(2):184-91. PubMed ID: 17366365
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR.
    Levin A.
    Nephrol Dial Transplant; 2007 Feb; 22(2):309-12. PubMed ID: 17234670
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hemoglobin target for chronic kidney disease patients?].
    Drüeke TB.
    Nephrol Ther; 2007 Oct; 3(6):369-71. PubMed ID: 17919639
    [No Abstract] [Full Text] [Related]

  • 13. Anemia: the point of convergence or divergence for kidney disease and heart failure?
    Kazory A, Ross EA.
    J Am Coll Cardiol; 2009 Feb 24; 53(8):639-47. PubMed ID: 19232895
    [Abstract] [Full Text] [Related]

  • 14. Comorbid diseases in patients on dialysis: the impact on anemia.
    Brattich M.
    Nephrol Nurs J; 2007 Feb 24; 34(1):72-5, 98. PubMed ID: 17345694
    [Abstract] [Full Text] [Related]

  • 15. European best practice guidelines 5: target haemoglobin.
    Jacobs C, Hörl WH, Macdougall IC, Valderrábano F, Parrondo I, Segner A, Abraham IL.
    Nephrol Dial Transplant; 2000 Feb 24; 15 Suppl 4():15-9. PubMed ID: 11052145
    [No Abstract] [Full Text] [Related]

  • 16. Creating a better environment to treat anemia in patients with CKD.
    Sinnen MT.
    Nephrol Nurs J; 2007 Feb 24; 34(6):645-9. PubMed ID: 18203573
    [No Abstract] [Full Text] [Related]

  • 17. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A, Sowers JR, McCullough PA, Roberts T, McFarlane SI, Chen SC, Li S, Wang C, Collins AJ, Bakris GL, KEEP Investigators.
    Am J Kidney Dis; 2009 Apr 24; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [Abstract] [Full Text] [Related]

  • 18. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
    Lucove J, Vupputuri S, Heiss G, North K, Russell M.
    Am J Kidney Dis; 2008 Jan 24; 51(1):21-8. PubMed ID: 18155529
    [Abstract] [Full Text] [Related]

  • 19. Effects of the Renin-Angiotensin system blockade on hemoglobin levels in type 2 diabetic patients with chronic kidney disease.
    Inoue A, Babazono T, Iwamoto Y.
    Am J Hypertens; 2008 Mar 24; 21(3):317-22. PubMed ID: 18202667
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 Mar 24; 24(3):625-37. PubMed ID: 18208642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.